Literature DB >> 24304616

Dendritic cells activated by double-stranded RNA induce arthritis via autocrine type I IFN signaling.

Sudeep Chenna Narendra1, Jaya Prakash Chalise, Nina Höök, Mattias Magnusson.   

Abstract

Viral dsRNA can be found at the site of inflammation in RA patients, and intra-articular injection of dsRNA induces arthritis by activating type I IFN signaling in mice. Further, DCs, a major source of IFN-α, can be found in the synovium of RA patients. We therefore determined the occurrence of DCs in dsRNA-induced arthritis and their ability to induce arthritis. Here, we show, by immunohistochemistry, that cells expressing the pan-DC marker CD11c and the pDC marker 120G8 are present in the inflamed synovium in dsRNA-induced arthritis. Flt3L-generated and splenic DCs preactivated with dsRNA before intra-articular injection, but not mock-stimulated cells, clearly induced arthritis. Induction of arthritis was dependent on type I IFN signaling in the donor DCs, whereas IFNAR expression in the recipient was not required. Sorting of the Flt3L-DC population into cDCs (CD11c(+), PDCA-1(-)) and pDCs (CD11c(+), PDCA-1(+)) revealed that both subtypes were arthritogenic and produced type I IFN if treated with dsRNA. Taken together, these results demonstrate that viral nucleic acids can elicit arthritis by activating type I IFN signaling in DCs. Once triggered, autocrine type I IFN signaling in dsRNA-activated DCs is sufficient to propagate arthritis.

Entities:  

Keywords:  cytokines; joint inflammation; viral nucleic acids

Mesh:

Substances:

Year:  2013        PMID: 24304616     DOI: 10.1189/jlb.0613320

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  8 in total

Review 1.  Arthritis models: usefulness and interpretation.

Authors:  Natacha Bessis; Patrice Decker; Eric Assier; Luca Semerano; Marie-Christophe Boissier
Journal:  Semin Immunopathol       Date:  2017-03-27       Impact factor: 9.623

2.  Levels of blood CD1c+ mDC1 and CD1chi mDC1 subpopulation reflect disease activity in noninfectious uveitis.

Authors:  Ping Chen; William Tucker; Susan Hannes; Baoying Liu; Han Si; Ankur Gupta; Richard W J Lee; H Nida Sen; Robert B Nussenblatt
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-12-16       Impact factor: 4.799

3.  Variation at FCGR2A and functionally related genes is associated with the response to anti-TNF therapy in rheumatoid arthritis.

Authors:  Gabriela Avila-Pedretti; Jesús Tornero; Antonio Fernández-Nebro; Francisco Blanco; Isidoro González-Alvaro; Juan D Cañete; Joan Maymó; Mercedes Alperiz; Benjamín Fernández-Gutiérrez; Alex Olivé; Héctor Corominas; Alba Erra; Adrià Aterido; María López Lasanta; Raül Tortosa; Antonio Julià; Sara Marsal
Journal:  PLoS One       Date:  2015-04-07       Impact factor: 3.240

4.  Nitro-fatty acids decrease type I interferons and monocyte chemoattractant protein 1 in ex vivo models of inflammatory arthritis.

Authors:  A L Hansen; L S J Rahbek; A S Sørensen; M P Hundahl; S Lomholt; C K Holm; Tue W Kragstrup
Journal:  BMC Immunol       Date:  2021-12-17       Impact factor: 3.615

5.  Interferon-α-mediated therapeutic resistance in early rheumatoid arthritis implicates epigenetic reprogramming.

Authors:  Faye A H Cooles; Jessica Tarn; Dennis W Lendrem; Najib Naamane; Chung Ma Lin; Ben Millar; Nicola J Maney; Amy E Anderson; Nishanthi Thalayasingam; Julie Diboll; Vincent Bondet; Darragh Duffy; Michael R Barnes; Graham R Smith; Sandra Ng; David Watson; Rafael Henkin; Andrew P Cope; Louise N Reynard; Arthur G Pratt; John D Isaacs
Journal:  Ann Rheum Dis       Date:  2022-06-09       Impact factor: 27.973

6.  The interferon gene signature is increased in patients with early treatment-naive rheumatoid arthritis and predicts a poorer response to initial therapy.

Authors:  Faye A H Cooles; Amy E Anderson; Dennis W Lendrem; Julie Norris; Arthur G Pratt; Catharien M U Hilkens; John D Isaacs
Journal:  J Allergy Clin Immunol       Date:  2017-10-05       Impact factor: 10.793

7.  Phenotypic and Transcriptomic Analysis of Peripheral Blood Plasmacytoid and Conventional Dendritic Cells in Early Drug Naïve Rheumatoid Arthritis.

Authors:  Faye A H Cooles; Amy E Anderson; Andrew Skelton; Arthur G Pratt; Mariola S Kurowska-Stolarska; Iain McInnes; Catharien M U Hilkens; John D Isaacs
Journal:  Front Immunol       Date:  2018-05-09       Impact factor: 7.561

8.  A Novel C Type CpG Oligodeoxynucleotide Exhibits Immunostimulatory Activity In Vitro and Enhances Antitumor Effect In Vivo.

Authors:  Tete Li; Jing Wu; Shan Zhu; Guoxia Zang; Shuang Li; Xinping Lv; Wenjun Yue; Yuan Qiao; Jiuwei Cui; Yan Shao; Jun Zhang; Yong-Jun Liu; Jingtao Chen
Journal:  Front Pharmacol       Date:  2020-02-06       Impact factor: 5.810

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.